PT - JOURNAL ARTICLE AU - Adiga, Aniruddha AU - Athreya, Siva AU - Lewis, Bryan AU - Marathe, Madhav V. AU - Rathod, Nihesh AU - Sundaresan, Rajesh AU - Swarup, Samarth AU - Venkatramanan, Srinivasan AU - Yasodharan, Sarath TI - Strategies to Mitigate COVID-19 Resurgence Assuming Immunity Waning: A Study for Karnataka, India AID - 10.1101/2021.05.26.21257836 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.26.21257836 4099 - http://medrxiv.org/content/early/2021/05/29/2021.05.26.21257836.short 4100 - http://medrxiv.org/content/early/2021/05/29/2021.05.26.21257836.full AB - COVID-19 vaccination is being rolled out among the general population in India. Spatial heterogeneities exist in seroprevalence and active infections across India. Using a spatially explicit age-stratified model of Karnataka at the district level, we study three spatial vaccination allocation strategies under different vaccination capacities and a variety of non-pharmaceutical intervention (NPI) scenarios. The models are initialised using on-the-ground datasets that capture reported cases, seroprevalence estimates, seroreversion and vaccine rollout plans. The three vaccination strategies we consider are allocation in proportion to the district populations, allocation in inverse proportion to the seroprevalence estimates, and allocation in proportion to the case-incidence rates during a reference period.The results suggest that the effectiveness of these strategies (in terms of cumulative cases at the end of a four-month horizon) are within 2% of each other, with allocation in proportion to population doing marginally better at the state level. The results suggest that the allocation schemes are robust and thus the focus should be on the easy to implement scheme based on population. Our immunity waning model predicts the possibility of a subsequent resurgence even under relatively strong NPIs. Finally, given a per-day vaccination capacity, our results suggest the level of NPIs needed for the healthcare infrastructure to handle a surge.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by Google Grants, the Centre for Networked Intelligence, the SERB-MATRICS grant, National Institutes of Health (NIH) Grant R01GM109718, NSF BIG DATA Grant IIS-1633028, NSF Grant No.: OAC-1916805, NSF Expeditions in Computing Grant CCF-1918656, NSF RAPID CNS-2028004, NSF RAPID OAC-2027541.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not requiredAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used is from publicly available data sources. https://des.kar.nic.in/docs/ProjectedPopulation2012-2021.pdf